CNBX PHARMACEUTICALS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CNBX PHARMACEUTICALS INC. (CNBX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 0 shares for the 12-month period ending 2021-08-31, per its 10-K filed 2021-11-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2021-11-29
- CNBX PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 0.00 shares.
- CNBX PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 0.00 shares.
- CNBX PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 0.00 shares.
- CNBX PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 0.00 shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2021-08-31 | 0.00 shares 10-K · filed 2021-11-29 |
| 2020-08-31 | 0.00 shares 10-K · filed 2021-11-29 |
| 2019-08-31 | 0.00 shares 10-K · filed 2020-11-04 |
| 2018-08-31 | 0.00 shares 10-K · filed 2019-11-29 |